维普中文期刊产品整合服务
6篇 您的检索式:作者名="Caldarella P"
    题名 作者 年代 出处 被引量
1Oligodendroglioma: CD44 as a possible prognostic opportunity显示文摘CD44, in its standard form as well in its isoforms, is a cell surface adhesion glycoprotein which occurs in a widevariety of non-neoplastic and neoplastic ceils. CD44 has been considered to be implicated in tumoral growth andin metastatic potential. We studied the immunohistochemical expression of CD44 standard in 30 oligodendrogliomas(19 primary lesions and 11 recurrences) in order to verify its possible prognostic role. Twelve primary oligoden-Buccoliero AM Caldarella A Arganini L Mennonna P Ammanati F Taddei A Taddei GL 2003中国神经肿瘤杂志2003,1,3:8
2School-wide Screening and Programs of Positive Behavior Support:Informing Universal Intervention显示文摘Marchant M Anderson H Caldarella P Fisher A Young J Young R 2009Preventing School Failure2009,,3:1
3Prokinetic effects in patients with intestinal gas retention显示文摘Caldarella M P Serra J Azpiroz F 2002Gastroenterology2002,122,7:1
4Antro-fundic dysfunctions in functional dyspepsia显示文摘Maria Pía Caldarella Fernando Azpiroz Juan-R Malagelada 2003Gastroenterology2003,,5:1
5Antro-fundic dysfunction in functional dyspepsia显示文摘 AZPIROZ F MALAGELADA J R 2003Gastroenterology2003,124,5:1
6Worldwide trends in esophageal cancer survival,by sub-site,morphology,and sex:an analysis of 696,974 adults diagnosed in 60 countries during 2000-2014(CONCORD-3)显示文摘Background Esophageal cancer survival is poor worldwide,though there is some variation.Differences in the distribution of anatomical sub-site and morphological sub-type may help explain international differences in survival for all esophageal cancers combined.We estimated survival by anatomic sub-site and morphological sub-type to understand further the impact of topography and morphology on international comparisons of esophageal cancer survival.Methods We estimated age-standardized one-year and five-year net survival among adults(15-99 years)diagnosed with esophageal cancer in each of 60 participating countries to monitor survival trends by calendar period of diagnosis(2000-2004,2005-2009,2010-2014),sub-site,morphology,and sex.Results For adults diagnosed during 2010-2014,tumors in the lower third of the esophagus were the most common,followed by tumors of overlapping sub-site and sub-site not otherwise specified.The proportion of squamous cell carcinomas diagnosed during 2010-2014 was generally higher in Asian countries(50%-90%),while adenocarcinomas were more common in Europe,North America and Oceania(50%-60%).From 2000-2004 to 2010-2014,the proportion of squamous cell carcinoma generally decreased,and the proportion of adenocarcinoma increased.Over time,there were few improvements in age-standardized five-year survival for each sub-site.Age-standardized one-year survival was highest in Japan for both squamous cell carcinoma(67.7%)and adenocarcinoma(69.0%),ranging between 20%-60%in most other countries.Age-standardized five-year survival from squamous cell carcinoma and adenocarcinoma was similar for most countries included,around 15%-20%for adults diagnosed during 2010-2014,though international variation was wider for squamous cell carcinoma.In most countries,survival for both squamous cell carcinoma and adenocarcinoma increased by less than 5%between 2000-2004 and 2010-2014.Conclusions Esophageal cancer survival remains poor in many countries.The distributions of sub-site and morphological sub-type vary between countries,but these differences do not fully explain international variation in esophageal cancer survival.Melissa Matz Mikhail Valkov Mario Šekerija Sabine Luttman Adele Caldarella Michel P Coleman Claudia Allemani the CONCORD Working Group 2023Cancer Communications2023,43,9:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费